Representative Ritchie Torres (D-New York) recently sold shares of Apple Inc. NASDAQ: AAPL. In a filing disclosed on August 20th, the Representative disclosed that they had sold between $1,001 and $15,000 in Apple stock on July 11th.
Representative Ritchie Torres also recently made the following trade(s):
- Sold $1,001 - $15,000 in shares of Equity Lifestyle Properties NYSE: ELS on 7/11/2025.
- Sold $1,001 - $15,000 in shares of Northrop Grumman NYSE: NOC on 7/11/2025.
- Sold $1,001 - $15,000 in shares of Emerson Electric NYSE: EMR on 7/11/2025.
- Sold $1,001 - $15,000 in shares of Kinder Morgan NYSE: KMI on 7/11/2025.
- Sold $1,001 - $15,000 in shares of MetLife NYSE: MET on 7/11/2025.
- Sold $1,001 - $15,000 in shares of Oracle NYSE: ORCL on 7/11/2025.
- Sold $1,001 - $15,000 in shares of Equity Residential NYSE: EQR on 7/11/2025.
- Sold $1,001 - $15,000 in shares of McKesson NYSE: MCK on 7/11/2025.
- Sold $1,001 - $15,000 in shares of Ares Management NYSE: ARES on 7/11/2025.
- Sold $1,001 - $15,000 in shares of Otis Worldwide NYSE: OTIS on 7/11/2025.
Apple Stock Up 1.3%
AAPL traded up $2.86 during trading on Friday, hitting $227.76. The stock had a trading volume of 42,410,143 shares, compared to its average volume of 57,406,027. The stock has a 50 day simple moving average of $211.89 and a two-hundred day simple moving average of $213.13. The company has a debt-to-equity ratio of 1.25, a quick ratio of 0.83 and a current ratio of 0.87. Apple Inc. has a twelve month low of $169.21 and a twelve month high of $260.10. The company has a market capitalization of $3.38 trillion, a PE ratio of 34.56, a PEG ratio of 2.37 and a beta of 1.16.
Apple (NASDAQ:AAPL - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The iPhone maker reported $1.57 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.43 by $0.14. The business had revenue of $94.04 billion for the quarter, compared to the consensus estimate of $88.64 billion. Apple had a return on equity of 170.91% and a net margin of 24.30%.The business's quarterly revenue was up 9.6% on a year-over-year basis. During the same period in the prior year, the firm posted $1.40 earnings per share. On average, research analysts predict that Apple Inc. will post 7.28 earnings per share for the current year.
Apple Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, August 14th. Investors of record on Monday, August 11th were given a dividend of $0.26 per share. The ex-dividend date of this dividend was Monday, August 11th. This represents a $1.04 dividend on an annualized basis and a yield of 0.5%. Apple's dividend payout ratio is presently 15.78%.
Apple announced that its board has approved a share buyback plan on Thursday, May 1st that permits the company to buyback $100.00 billion in shares. This buyback authorization permits the iPhone maker to reacquire up to 3.1% of its shares through open market purchases. Shares buyback plans are usually a sign that the company's leadership believes its stock is undervalued.
Insider Activity at Apple
In related news, SVP Deirdre O'brien sold 34,821 shares of the stock in a transaction on Friday, August 8th. The stock was sold at an average price of $223.20, for a total value of $7,772,047.20. Following the completion of the transaction, the senior vice president directly owned 136,687 shares of the company's stock, valued at approximately $30,508,538.40. This represents a 20.30% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.06% of the company's stock.
Analysts Set New Price Targets
AAPL has been the subject of several recent analyst reports. TD Cowen lowered their price target on Apple from $290.00 to $275.00 and set a "buy" rating for the company in a report on Friday, May 2nd. Citigroup lifted their target price on shares of Apple from $240.00 to $245.00 and gave the stock a "buy" rating in a research note on Friday, August 1st. JPMorgan Chase & Co. upped their price target on shares of Apple from $250.00 to $255.00 and gave the company an "overweight" rating in a research note on Friday, August 1st. UBS Group lifted their price objective on shares of Apple from $210.00 to $220.00 and gave the stock a "neutral" rating in a research note on Friday, August 1st. Finally, Monness Crespi & Hardt boosted their price objective on shares of Apple from $245.00 to $270.00 and gave the company a "buy" rating in a report on Friday, August 1st. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eleven have assigned a Hold rating and two have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $237.98.
Read Our Latest Research Report on Apple
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of the stock. Ryan Investment Management Inc. purchased a new position in shares of Apple during the 2nd quarter valued at approximately $31,000. ROSS JOHNSON & Associates LLC raised its position in shares of Apple by 1,800.0% during the 1st quarter. ROSS JOHNSON & Associates LLC now owns 190 shares of the iPhone maker's stock worth $42,000 after purchasing an additional 180 shares during the last quarter. Life Planning Partners Inc purchased a new position in Apple in the 4th quarter valued at about $47,000. Nexus Investment Management ULC boosted its holdings in Apple by 333.3% in the 2nd quarter. Nexus Investment Management ULC now owns 260 shares of the iPhone maker's stock worth $53,000 after buying an additional 200 shares during the last quarter. Finally, Elite Financial Inc. acquired a new position in shares of Apple during the first quarter valued at approximately $58,000. 67.73% of the stock is currently owned by hedge funds and other institutional investors.
About Representative Torres
Ritchie Torres (Democratic Party) is a member of the U.S. House, representing New York's 15th Congressional District. He assumed office on January 3, 2021. His current term ends on January 3, 2027.
Torres (Democratic Party) ran for re-election to the U.S. House to represent New York's 15th Congressional District. He won in the general election on November 5, 2024.
Ritchie Torres lives in the Bronx, New York.
Apple Company Profile
(
Get Free Report)
Apple Inc designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide. The company offers iPhone, a line of smartphones; Mac, a line of personal computers; iPad, a line of multi-purpose tablets; and wearables, home, and accessories comprising AirPods, Apple TV, Apple Watch, Beats products, and HomePod.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Apple, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Apple wasn't on the list.
While Apple currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report